Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy-Reference-Cited by-同舟云学术

Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy

Published:2021-11-16 Issue:22 Volume:64 Page:16650-16674
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Zhuqing¹²,Guo Zuhao³²,Xu Xiaowei¹²,Cao Danyan³,Yang Hong¹,Li Yanlian³,Shi Qiongyu¹,Du Zhiyan³,Guo Xiaobin¹,Wang Xin³,Chen Danqi³,Zhang Ying¹²,Chen Lin³,Zhou Kaixin³,Li Jian⁴,Geng Meiyu¹²⁵,Huang Xun¹²⁵,Xiong Bing³²^ORCID

Affiliation:

1. Division of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. China

2. University of Chinese Academy of Sciences, NO.19A Yuquan Road, Beijing 100049, P. R. China

3. Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. China

4. College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, P. R. China

5. Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, P. R. China

Funder

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

American Heart Association

Georgia Cancer Coalition

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Georgia State University

State Key Laboratory of Drug Research

Jiangxi "Double Thousand Plan"

Shanghai Municipal Commission of Health and Family Planning